Global Electrophoresis Market expected to hit USD 4.01 Bn by 2029 from USD 2.7 Bn in 2022 at a CAGR of 5.8% during the forecast periodElectrophoresis Market Overview
Electrophoresis is a process of separating charged particles in a fluid using an electrical charge. The process is used in the healthcare system to separate DNA based on Application, density, and purity.Increased demand for personalized diagnosis and medicines is expected to boost the Electrophoresis Market.The industry is growing steadily due to the increasing medical research fields such asgenomics, proteomics, and personalized medicine. Also, the rising cases of chronic diseases and the need for the development of drugs with accurate result and the equality control processes are expected to boost the growth of the market over the forecast period(2023-2029).To know about the Research Methodology :- Request Free Sample Report
Electrophoresis Market Dynamics
Use of Electrophoresis in DNA Analysis and Protein and Antibody Interactions Expected to Boost Electrophoresis Market Electrophoresis is widely used in the study and identification of DNA since it contains a negative charge and separates smaller and larger fragments of DNA. Medical researchers use the gel as a medium to examine molecules at high resolutions when an electric charge is used. This system improves the accuracy and correctness of the research and is popular in the research field. These factors are expected to drive the Electrophoresis Market.The major Electrophoresis Key Companies are investing and seeking a skilled workforce to develop easier electrophoresis processes, which is expected to increase their Electrophoresis Market Size.The electrophoresis system is present in several forms such as immuno electrophoresis, which is used to observe the presence and behavior of specificproteins in the human body. Medical situations such as kidney disease and sclerosissome times create a protein imbalance.The electrophoresis system helps to diagnose these abnormal protein molecules.This is expected to drive the Electrophoresis Market. Vaccine Creation and Genetic and Antibiotics Testing Expected to Boost the Demand for Electrophoresis Reagents Electrophoresis separates antibodies from impurities in the antibiotic and helps in understanding the concentration of antibiotic to increase the accuracy and effect of dosage. Diseases such as bacterial infection, tuberculosis and MRSA requires antibiotictests otherwise it is hard to treat.The increasing number of cases of these diseasesis expected to drive the Electrophoresis Market. Electrophoresisis used for the creation, production and testing of vaccines. During the production of vaccines,electrophoresis provides an easy, quick and effective way of testing to maintain consistency and purity. This provides the concentration of antigens, proteins and nucleic acids in the vaccine to decide the purity, effectiveness and safety of the vaccine.The system is emerging as an impressive method in the diagnosis of microalbuminuria, Alzheimer’s and Parkinson’s diseases, pheochromocytoma, neuroblastoma, and urinary stone disease High-Cost of Electrophoresis Reagents Expected to Limit the Growth of the Market The report provides detailed data collected from primary and secondary research methods and later analyzed by SWOT analysis, PESTLE analysis and PORTER’s five force model. This includes the growth drivers, opportunities, regional insights and constraints of the Electrophoresis Market. The market growth is limited by the high cost of electrophoresis reagents and types of equipment. Also, the electrophoresis technique requires skilled professionals that are less in the industry and the emerging alternative technologies and their adoption is expected to impede the growth of the Electrophoresis Market.Electrophoresis Market Competitive Landscape
The report provides a detailed competitive landscape of the Electrophoresis Key Players to understand the Electrophoresis Market Share and Electrophoresis Market Penetration in the major geographic regions such as North America, South America, Asia Pacific, the Middle East and Africa and Europe. ThermoFisher Scientific, Qiagen NV, Danaher and Merck & Co. Inc. are some of the major Electrophoresis Key Companies. Recently, in October 31, 2022, Thermo Fisher Scientific announced its acquisition of the Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at US $2.8 billion at current exchange rates. The Binding group is expected to expand Thermo Fisher Scientific’s existing specialty diagnostics portfolio with the addition of pioneering innovation in diagnostics and monitoring for multiple myeloma. Early diagnosis and well-informed treatment decisions are expected to make a significant difference in patient outcomes. This is expected to drive the Global Electrophoresis Market.Electrophoresis Market Segment Analysis
Based on Product The Electrophoresis reagents segment is expected to hold the largest revenue share in the Electrophoresis Market. The growing need for genetic diagnosis and research is due to increased infectious diseases in young and aged populations. The results derived through the electrophoresis reagents are quick and accurate. This factor is driving the demand and popularity of electrophoresis reagents in the medical research field. The Electrophoresis Key Companies are continuously investing to develop an easy and less harmful process of diagnosis and separation of DNA.Based on Application The research segment held the largest share of the market in 2022 and is expected to dominate the market during the forecast period. The electrophoresis diagnosis system is not widely accepted and has a mixed acceptance rate due to confidentiality. Hence, there is ongoing and continuous research on electrophoresis, which is expected to drive the research segment in the Electrophoresis Market. The research in the medical field is growing exponentially that is driving the growth of the market. Based on the End User The Pharmaceutical and Biotechnology Companies segment dominated the market in 2022 and is expected to grow significantly throughout the forecast period (2023-2029). Electrophoresis is an alternative method to liquid chromatography-mass spectrometry in mapping DNA and other biological components. Many Pharmaceutical and Biotechnology Companies are using electrophoresis systems to perform mass analysis of DNA, charge variant analysis, impurity analysis and mapping analysis and bio similar comparisons for the research. These factors are expected to propel the segment’s growth in the Electrophoresis Market. Electrophoresis Market Regional Insights North America held the largest share in the Electrophoresis Market in 2022 and is expected to dominate the market throughout the forecast period. The countries in the region such as the United States and Canada and others spend the highest expenditure on healthcare infrastructure and research and development. The secountriesfund medical research organizations for the improvement of the diagnosis systems.Also, the presence of major Electrophoresis Key Companies in the region is expected to drive the North America Electrophoresis Market. Asia Pacific is expected to grow significantly throughout the forecast period(2023-2029) in the market.The growing emphasis of the government on the development of healthcare infrastructure, especially after the COVID-19 pandemic and the need for personalized diagnosis and medications is expected todrive the Asia Pacific Electrophoresis Market. These factors are expected to create a lucrative investment opportunity for Electrophoresis Key Players.The growing adoption of electrophoretic techniques in medical testing such as plasma, serum, urine and hemoglobin testing and others are driving the growth of the region’s Electrophoresis Industry.
Electrophoresis Market Scope: Inquire before buying
Global Electrophoresis Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.7 Bn. Forecast Period 2023 to 2029 CAGR: 5.8% Market Size in 2029: US $ 4.01 Bn. Segments Covered: by Product Electrophoresis Systems Product Gel Electrophoresis Systems Capillary Electrophoresis Systems Gel Documentation Systems and Software Electrophoresis Reagents Product Protein Electrophoresis Reagents Nucleic Acid Electrophoresis Reagents by End-User Academic Institutions Hospitals and Diagnostic Centers harmaceutical and Biotechnology Companies Research Organizations by Application Diagnostic Research Quality Control and Process Validation Electrophoresis Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players:
1. Schimadzu 2. Perkinelmer 3. Agilent 4. Bio-Rad Corporation 5. Harvard 6. LONZA GROUP 7. ThermoFisher Scientific 8. Qiagen NV 9. Danaher 10. Merck & Co. Inc. Frequently Asked Questions: 1] What is the growth rate of the Market? Ans. The Electrophoresis Market is growing at a CAGR of 5.8% during the forecast period. 2] Which region is expected to dominate the Market? Ans. North America is expected to dominate the Electrophoresis Market during the forecast period from 2023 to 2029. 3] What is the expected Electrophoresis Market Application by 2029? Ans. The Application of the Electrophoresis Market by 2029 is expected to reach USD 4.01 Bn. 4] Who are the top players in the Electrophoresis Market? Ans. The major key players in the Electrophoresis Market are PlayPower, Inc. (EZ Dock), ShoreMaster, Dock Doctors and On the Water Designs 5] Which factors contributed to the growth of the Electrophoresis Market in 2022? Ans. The Electrophoresis Market is expected to grow due to the rising medical research and studies.
TOC: 1. Electrophoresis Market: Research Methodology 2. Electrophoresis Market: Executive Summary 3. Electrophoresis Market: Competitive Landscape 3.1. MMR Competition Matrix 3.2. Competitive Landscape 3.3. Key Players Benchmarking 3.4. Market Structure 3.4.1. Market Leaders 3.4.2. Market Followers 3.4.3. Emerging Players 3.5. Consolidation of the Market 4. Electrophoresis Market: Dynamics 4.1. Market Trends by Region 4.1.1. North America 4.1.2. Europe 4.1.3. Asia Pacific 4.1.4. Middle East and Africa 4.1.5. South America 4.2. Market Drivers by Region 4.2.1. North America 4.2.2. Europe 4.2.3. Asia Pacific 4.2.4. Middle East and Africa 4.2.5. South America 4.3. Market Restraints 4.4. Market Opportunities 4.5. Market Challenges 4.6. PORTER’s Five Forces Analysis 4.7. PESTLE Analysis 4.8. Value Chain Analysis 4.9. Regulatory Landscape by Region 4.9.1. North America 4.9.2. Europe 4.9.3. Asia Pacific 4.9.4. Middle East and Africa 4.9.5. South America 5. Electrophoresis MarketApplication and Forecast by Segments (by Value USD and Volume Units) 5.1. Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 5.1.1. ELECTROPHORESIS SYSTEMS 5.1.1.1. Product 5.1.1.2. Gel Electrophoresis Systems 5.1.1.3. Capillary Electrophoresis Systems 5.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 5.1.3. Electrophoresis Reagents 5.1.3.1. Product 5.1.3.2. Protein Electrophoresis Reagents 5.1.3.3. Nucleic Acid Electrophoresis Reagents 5.2. Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 5.2.1. Diagnostic 5.2.2. Research 5.2.3. Quality Control and Process Validation 5.3. Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 5.3.1. ACADEMIC INSTITUTIONS 5.3.2. HOSPITALS AND DIAGNOSTIC CENTERS 5.3.3. Pharmaceutical and Biotechnology Companies 5.3.4. Research Organizations 5.4. Electrophoresis MarketApplication and Forecast, by Region (2022-2029) 5.4.1. North America 5.4.2. Europe 5.4.3. Asia Pacific 5.4.4. Middle East and Africa 5.4.5. South America 6. North America Electrophoresis MarketApplication and Forecast (by Value USD and Volume Units) 6.1. North America Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 6.1.1. ELECTROPHORESIS SYSTEMS 6.1.1.1. Product 6.1.1.2. Gel Electrophoresis Systems 6.1.1.3. Capillary Electrophoresis Systems 6.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 6.1.3. Electrophoresis Reagents 6.1.3.1. Product 6.1.3.2. Protein Electrophoresis Reagents 6.1.3.3. Nucleic Acid Electrophoresis Reagents 6.2. North America Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 6.2.1. Diagnostic 6.2.2. Research 6.2.3. Quality Control and Process Validation 6.3. North America Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 6.3.1. ACADEMIC INSTITUTIONS 6.3.2. HOSPITALS AND DIAGNOSTIC CENTERS 6.3.3. Pharmaceutical and Biotechnology Companies 6.3.4. Research Organizations 6.4. North America Electrophoresis MarketApplication and Forecast, by Country (2022-2029) 6.4.1. United States 6.4.2. Canada 6.4.3. Mexico 7. Europe Electrophoresis MarketApplication and Forecast (by Value USD and Volume Units) 7.1. Europe Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 7.1.1. ELECTROPHORESIS SYSTEMS 7.1.1.1. Product 7.1.1.2. Gel Electrophoresis Systems 7.1.1.3. Capillary Electrophoresis Systems 7.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 7.1.3. Electrophoresis Reagents 7.1.3.1. Product 7.1.3.2. Protein Electrophoresis Reagents 7.1.3.3. Nucleic Acid Electrophoresis Reagents 7.2. Europe Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 7.2.1. Diagnostic 7.2.2. Research 7.2.3. Quality Control and Process Validation 7.3. Europe Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 7.3.1. ACADEMIC INSTITUTIONS 7.3.2. HOSPITALS AND DIAGNOSTIC CENTERS 7.3.3. Pharmaceutical and Biotechnology Companies 7.3.4. Research Organizations 7.4. Europe Electrophoresis MarketApplication and Forecast, by Country (2022-2029) 7.4.1. UK 7.4.2. France 7.4.3. Germany 7.4.4. Italy 7.4.5. Spain 7.4.6. Sweden 7.4.7. Austria 7.4.8. Rest of Europe 8. Asia Pacific Electrophoresis MarketApplication and Forecast (by Value USD and Volume Units) 8.1. Asia Pacific Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 8.1.1. ELECTROPHORESIS SYSTEMS 8.1.1.1. Product 8.1.1.2. Gel Electrophoresis Systems 8.1.1.3. Capillary Electrophoresis Systems 8.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 8.1.3. Electrophoresis Reagents 8.1.3.1. Product 8.1.3.2. Protein Electrophoresis Reagents 8.1.3.3. Nucleic Acid Electrophoresis Reagents 8.2. Asia Pacific Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 8.2.1. Diagnostic 8.2.2. Research 8.2.3. Quality Control and Process Validation 8.3. Asia Pacific Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 8.3.1. Academic Institutions 8.3.2. Hospitals and Diagnostic Centers 8.3.3. Pharmaceutical and Biotechnology Companies 8.3.4. Research Organizations 8.4. Asia Pacific Electrophoresis MarketApplication and Forecast, by Country (2022-2029) 8.4.1. China 8.4.2. S Korea 8.4.3. Japan 8.4.4. India 8.4.5. Australia 8.4.6. Indonesia 8.4.7. Malaysia 8.4.8. Vietnam 8.4.9. Taiwan 8.4.10. Bangladesh 8.4.11. Pakistan 8.4.12. Rest of Asia Pacific 9. Middle East and Africa Electrophoresis MarketApplication and Forecast (by Value USD and Volume Units) 9.1. Middle East and Africa Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 9.1.1. ELECTROPHORESIS SYSTEMS 9.1.1.1. Product 9.1.1.2. Gel Electrophoresis Systems 9.1.1.3. Capillary Electrophoresis Systems 9.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 9.1.3. Electrophoresis Reagents 9.1.3.1. Product 9.1.3.2. Protein Electrophoresis Reagents 9.1.3.3. Nucleic Acid Electrophoresis Reagents 9.2. Middle East and Africa Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 9.2.1. Diagnostic 9.2.2. Research 9.2.3. Quality Control and Process Validation 9.3. Middle East and Africa Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 9.3.1. Academic Institutions 9.3.2. Hospitals and Diagnostic Centers 9.3.3. Pharmaceutical and Biotechnology Companies 9.3.4. Research Organizations 9.4. Middle East and Africa Electrophoresis MarketApplication and Forecast, by Country (2022-2029) 9.4.1. South Africa 9.4.2. GCC 9.4.3. Egypt 9.4.4. Nigeria 9.4.5. Rest of ME&A 10. South America Electrophoresis MarketApplication and Forecast (by Value USD and Volume Units) 10.1. South America Electrophoresis MarketApplication and Forecast, by Product (2022-2029) 10.1.1. ELECTROPHORESIS SYSTEMS 10.1.1.1. Product 10.1.1.2. Gel Electrophoresis Systems 10.1.1.3. Capillary Electrophoresis Systems 10.1.2. GEL DOCUMENTATION SYSTEMS AND SOFTWARE 10.1.3. Electrophoresis Reagents 10.1.3.1. Product 10.1.3.2. Protein Electrophoresis Reagents 10.1.3.3. Nucleic Acid Electrophoresis Reagents 10.2. South America Electrophoresis MarketApplication and Forecast, by Application (2022-2029) 10.2.1. Diagnostic 10.2.2. Research 10.2.3. Quality Control and Process Validation 10.3. South America Electrophoresis MarketApplication and Forecast, by End User (2022-2029) 10.3.1. Academic Institutions 10.3.2. Hospitals and Diagnostic Centers 10.3.3. Pharmaceutical and Biotechnology Companies 10.3.4. Research Organizations 10.4. South America Electrophoresis MarketApplication and Forecast, by Country (2022-2029) 10.4.1. Brazil 10.4.2. Argentina 10.4.3. Rest of South America 11. Company Profile: Key players 11.1. Schimadzu 1.1.1. Company Overview 1.1.2. Financial Overview 1.1.3. Business Portfolio 1.1.4. SWOT Analysis 1.1.5. Business Strategy 1.1.6. Recent Developments 11.2. Perkinelmer 11.3. Agilent 11.4. Bio-Rad Corporation 11.5. Harvard 11.6. LONZA GROUP 11.7. ThermoFisher Scientific 11.8. Qiagen NV 11.9. Danaher 11.10. Merck & Co. Inc. 12. Key Findings 13. Industry Recommendation